0001873311-21-000001.txt : 20210720 0001873311-21-000001.hdr.sgml : 20210720 20210719183347 ACCESSION NUMBER: 0001873311-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210720 DATE AS OF CHANGE: 20210719 EFFECTIVENESS DATE: 20210720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Modulus Therapeutics, Inc. CENTRAL INDEX KEY: 0001873311 IRS NUMBER: 853561212 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-406833 FILM NUMBER: 211098912 BUSINESS ADDRESS: STREET 1: 2101 N. 34TH ST. STREET 2: STE.195 CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 801-534-7260 MAIL ADDRESS: STREET 1: 2101 N. 34TH ST. STREET 2: STE.195 CITY: SEATTLE STATE: WA ZIP: 98103 D 1 primary_doc.xml X0708 D LIVE 0001873311 Modulus Therapeutics, Inc. 2101 N. 34TH ST. STE.195 SEATTLE WA WASHINGTON 98103 801-534-7260 DELAWARE None None Corporation true 2020 Bryce R Daines 2101 N. 34th St. Ste. 195 Seattle WA WASHINGTON 98103 Executive Officer Director Max C Darnell 2101 N. 34th St. Ste. 195 Seattle WA WASHINGTON 98103 Executive Officer Director Biotechnology No Revenues 06b false 2021-07-02 false true false 125000 3776000 3776000 0 false 9 0 0 0 false Modulus Therapeutics, Inc. Bryce R Daines Bryce R Daines President 2021-07-19